Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products. [electronic resource]
Producer: 20180717Description: 303-308 p. digitalISSN:- 1937-6995
- Acetaminophen -- adverse effects
- Acetylcysteine -- therapeutic use
- Adolescent
- Adult
- Analgesics, Non-Narcotic -- adverse effects
- Chemical and Drug Induced Liver Injury -- drug therapy
- Databases, Factual
- Drug Approval -- legislation & jurisprudence
- Drug Combinations
- Drug Compounding
- Drug Overdose -- drug therapy
- Drug and Narcotic Control -- legislation & jurisprudence
- Female
- Humans
- Male
- Middle Aged
- Naloxone -- therapeutic use
- Narcotic Antagonists -- adverse effects
- Poison Control Centers
- Policy Making
- Pregnancy
- Prescription Drugs -- adverse effects
- Program Evaluation
- Protective Factors
- Risk Factors
- Time Factors
- United States
- United States Food and Drug Administration -- legislation & jurisprudence
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.